In a pioneering medical procedure, four women underwent surgery to reduce their risk of ovarian cancer simultaneously with Caesarean deliveries.
This groundbreaking two-in-one operation, conducted at a London hospital, aimed to reduce the women's cancer risk by removing their ovaries and fallopian tubes.
This procedure is significant because it eliminates the need for a separate surgery to address the cancer risk, sparing women the anxiety and uncertainty of waiting for a later operation.
While the surgery can be complex and carries risks such as early menopause and increased blood loss, it offers a valuable option for women at high risk of ovarian cancer due to genetic factors like BRCA1 or BRCA2 gene variants.